Effect of Melatonin on the Release of Gonadotropin-Releasing Hormone and Cyclic AMP from the Rat Hypothalamus: an in vitro Study

Using an in vitro static incubation system of adult male rat hypothalami, we have studied the effect of melatonin on the release of gonadotropin‐releasing hormone (GnRH) and cyclic adenosine monophosphate (cAMP). Mediobasal hypothalamus (MBH) and preoptic area (POA) were incubated separately in Mini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroendocrinology 1996-10, Vol.8 (10), p.801-807
Hauptverfasser: Messager, S., Caillol, M., Rossano, B., Martinet, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Using an in vitro static incubation system of adult male rat hypothalami, we have studied the effect of melatonin on the release of gonadotropin‐releasing hormone (GnRH) and cyclic adenosine monophosphate (cAMP). Mediobasal hypothalamus (MBH) and preoptic area (POA) were incubated separately in Minimum Essential Medium (MEM) for 6 h. The release of GnRH was measured by radioimmunoassay in the incubation medium sampled every 7.5 min. In the MBH and POA incubation medium, the mean amount of GnRH released was 8.9±1.1 and 3.4±0.6 pg GnRH/7.5 min, respectively (P0.05). Melatonin (10−8 M) did not alter the release of GnRH in the presence or absence of forskolin (10−4 M). Melatonin, which was without effect on basal cAMP, inhibited forskolin‐stimulated cAMP accumulation in the medium by 50% in the MBH and 40% in the POA. These results suggest that in our incubation system, melatonin does not modify GnRH release, but probably acts through the melatonin binding sites located in the hypothalamus to inhibit forskolin‐stimulated cAMP.
ISSN:0953-8194
1365-2826
DOI:10.1046/j.1365-2826.1996.52711.x